echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > [quick news] on February 26, 2020, reduce the decomposition temperature of pollutants and make the regeneration of membrane materials more energy-saving

    [quick news] on February 26, 2020, reduce the decomposition temperature of pollutants and make the regeneration of membrane materials more energy-saving

    • Last Update: 2020-02-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the research team of membrane separation and catalysis research group of Qingdao Institute of bioenergy and process of Chinese Academy of Sciences has successfully developed functional perovskite oxide porous membrane and energy-saving regeneration technology, which is a new type of perovskite oxide development and catalysis in China - important scientific and technological achievements in the study of membrane separation performance In this work, the photothermal and catalytic properties of perovskite oxide are used cleverly to solve the problem of biological pollution in practical application Http://digitalpaper.stdaily.com/http_ HTM? Div = - 1 There is a more economic way to recycle waste Scientists from Tomsk University of technology in Russia have developed a way to recycle industrial and urban waste as a mixed fuel component in a combustion way Hybrid fuel is a kind of modern new energy in thermal power plant, which can replace coal to produce electric energy and heat energy Compared with coal, hybrid fuel has the advantage of low cost, and the basic cost depends on the transportation and preparation of various components In addition, the content of sulfur and nitrogen oxides in the exhaust gas from the mixed fuel is low The results were published in the journal energy Http://digitalpaper.stdaily.com/http_ Div = - 1 American media said that new cholesterol lowering drugs were approved in the United States: applicable to more than 100 million people According to the associated press, the United States Food and Drug Administration (FDA) approved nexletol, a new drug developed by esperan pharmaceutical company The drug is intended for people with high levels of congenital cholesterol, as well as people with heart disease who need to further reduce the level of "bad cholesterol" The daily drug needs to be combined with a healthy diet, and patients who use the highest dose of statins can also use it, the FDA said In a study funded by esperan pharmaceuticals, the common side effects of nexletol include high blood pressure and muscle and joint pain Serious side effects include tendon rupture The FDA said pregnant and lactating women should not use nexletol because it may cause harm to the fetus or baby Http:// recently, Chinese scholars analyzed the genome and landing mechanism of early landing plant corydalis Chen Zhiduan, researcher of Institute of Botany, Chinese Academy of Sciences, Liu Zhongjian, Professor of Fujian agricultural and Forestry University, Zhang Shouzhou, Professor of Shenzhen Xianhu botanical garden, Yves Van de, University of Ghent, Belgium Professor peer and others jointly published an article entitled the hornwort genome and early land plant evolution on the top botanical journal nature plants online Hornwort is the only group of bryophytes with high quality reference genome that has not been completely resolved This study makes up for this gap, and further reveals the unique characteristics of hornwort genome and the adaptation mechanism of this group to land environment Http:// new coronavirus vaccine development! Clover novel coronavirus and GlaxoSmithKline R & D cooperation, clover bio Pharmaceuticals Limited (hereinafter referred to as "clover") has announced that it will cooperate with the vaccine giant GSK to promote research and development of its protein based new coronavirus vaccine "COVID-19 S- trimer" GSK will provide a vaccine adjuvant system for clover organisms to prevent disease pandemics in order to further evaluate the "s-trimer" in preclinical studies Novel coronavirus vaccine will be rapidly expanded by the cooperation, which is one of the largest cGMP biotech production capacity in China http://
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.